# Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.

> **NCT03572777** · NA · COMPLETED · sponsor: **Antonio Mestrovic** · enrollment: 159 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Concomitant therapy
- **DRUG:** Concomitant therapy
- **DRUG:** Concomitant therapy
- **DRUG:** Concomitant therapy
- **DRUG:** Hybrid therapy
- **DRUG:** Hybrid therapy
- **DRUG:** Hybrid therapy
- **DRUG:** Hybrid therapy

## Key facts

- **NCT ID:** NCT03572777
- **Lead sponsor:** Antonio Mestrovic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-15
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-15
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2021-01-26

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03572777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03572777, "Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03572777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*